Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for GH

Stock NameGuardant Health Inc
TickerGH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS40131M1099
LEI254900M8C3E5VC8BR186

Show aggregate GH holdings

News associated with GH

GH Crosses Above Average Analyst Target
In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $59.43, changing hands for $60.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va - 2025-08-15 09:41:48
Deutsche Bank AG Sells 30,534 Shares of Guardant Health, Inc. (NASDAQ:GH)
Deutsche Bank AG cut its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The fund owned 746,636 shares of the company’s stock after selling 30,534 shares during the period. Deutsche Bank AG’s holdings in Guardant Health were worth $31,807,000 as of its most […] - 2025-08-13 05:19:03
XTX Topco Ltd Sells 26,522 Shares of Guardant Health, Inc. (NASDAQ:GH)
XTX Topco Ltd cut its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 84.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,935 shares of the company’s stock after selling 26,522 shares during the quarter. XTX […] - 2025-08-13 04:28:44
Brokerages Set Guardant Health, Inc. (NASDAQ:GH) PT at $54.45
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has received a consensus rating of “Buy” from the twenty ratings firms that are covering the stock, Marketbeat.com reports. Nineteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price target […] - 2025-08-01 03:08:57
Guardant Health (GH) Q2 Revenue Up 31%
Key PointsRevenue soared 31% year over year to $232.1 million in Q2 2025, beating analyst estimates by $20.6 million for Q2 2025. - 2025-07-31 06:06:40
KLP Kapitalforvaltning AS Has $1 Million Holdings in Guardant Health, Inc. (NASDAQ:GH)
KLP Kapitalforvaltning AS cut its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 5.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,500 shares of the company’s stock after selling 1,300 shares during the period. KLP Kapitalforvaltning […] - 2025-07-29 05:28:52
Guardant Health, Inc. (NASDAQ:GH) Stake Boosted by New York State Common Retirement Fund
New York State Common Retirement Fund grew its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 184.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 106,884 shares of the company’s stock after purchasing an additional 69,257 shares during […] - 2025-07-22 07:10:51
SBI Securities Co. Ltd. Lowers Stock Holdings in Guardant Health, Inc. (NASDAQ:GH)
SBI Securities Co. Ltd. reduced its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 51.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 685 shares of the company’s stock after selling 730 shares during the period. SBI Securities Co. Ltd.’s holdings in Guardant Health were […] - 2025-07-21 05:22:55
Edgestream Partners L.P. Buys New Shares in Guardant Health, Inc. (NASDAQ:GH)
Edgestream Partners L.P. bought a new stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 20,425 shares of the company’s stock, valued at approximately $870,000. Several other large investors have also recently bought and sold shares of GH. Raymond James Financial Inc. acquired […] - 2025-07-20 06:02:53
Analysts Anticipate FMDE Will Reach $38
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-17 10:38:36
Gamehost (TSE:GH) Hits New 12-Month High Following Dividend Announcement
Gamehost Inc. (TSE:GH – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday following a dividend announcement from the company. The company traded as high as C$12.28 and last traded at C$12.28, with a volume of 3378 shares trading hands. The stock had previously closed at C$12.14. The newly announced […] - 2025-07-02 02:26:54
Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells $322,791.36 in Stock
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) Director Ian T. Clark sold 6,672 shares of the business’s stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $48.38, for a total value of $322,791.36. Following the completion of the sale, the director now owns 9,851 […] - 2025-06-23 05:24:54
Fifth Third Bancorp Acquires New Holdings in Guardant Health, Inc. (NASDAQ:GH)
Fifth Third Bancorp acquired a new position in Guardant Health, Inc. (NASDAQ:GH – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 6,560 shares of the company’s stock, valued at approximately $279,000. A number of other hedge funds […] - 2025-06-19 05:05:05
Guardant Health (NASDAQ:GH) Given New $65.00 Price Target at Mizuho
Guardant Health (NASDAQ:GH – Free Report) had its price target raised by Mizuho from $60.00 to $65.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Raymond James reiterated an […] - 2025-06-16 02:50:49
Rhumbline Advisers Buys 8,202 Shares of Guardant Health, Inc. (NASDAQ:GH)
Rhumbline Advisers boosted its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 4.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 175,432 shares of the company’s stock after buying an additional 8,202 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-06-12 05:08:52
Amirali Talasaz Sells 39,751 Shares of Guardant Health, Inc. (NASDAQ:GH) Stock
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) CEO Amirali Talasaz sold 39,751 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $50.07, for a total value of $1,990,332.57. Following the completion of the sale, the chief executive officer now directly […] - 2025-06-11 05:19:04
Amirali Talasaz Sells 77,853 Shares of Guardant Health, Inc. (NASDAQ:GH) Stock
Guardant Health, Inc. (NASDAQ:GH – Get Free Report) CEO Amirali Talasaz sold 77,853 shares of the stock in a transaction that occurred on Monday, June 9th. The stock was sold at an average price of $50.09, for a total value of $3,899,656.77. Following the transaction, the chief executive officer now owns 2,069,456 shares in the […] - 2025-06-11 05:18:57
GAMMA Investing LLC Raises Position in Guardant Health, Inc. (NASDAQ:GH)
GAMMA Investing LLC increased its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 11,765.1% during the first quarter, HoldingsChannel reports. The institutional investor owned 17,679 shares of the company’s stock after acquiring an additional 17,530 shares during the quarter. GAMMA Investing LLC’s holdings in Guardant Health were worth $7,530,000 at the end of […] - 2025-06-09 05:12:48
California State Teachers Retirement System Sells 749 Shares of Guardant Health, Inc. (NASDAQ:GH)
California State Teachers Retirement System trimmed its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 0.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,687 shares of the company’s stock after selling 749 shares during the period. California State Teachers […] - 2025-06-05 05:28:52
Guardant Health, Inc. (NASDAQ:GH) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,180 shares of the company’s stock after acquiring an additional 2,562 […] - 2025-05-22 07:41:08
Janus Henderson Group PLC Sells 3,900 Shares of Guardant Health, Inc. (NASDAQ:GH)
Janus Henderson Group PLC trimmed its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 56,678 shares of the company’s stock after selling 3,900 shares during the […] - 2025-05-22 06:48:59
Focus Partners Wealth Buys Shares of 17,896 Guardant Health, Inc. (NASDAQ:GH)
Focus Partners Wealth bought a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,896 shares of the company’s stock, valued at approximately $547,000. Several other large investors also recently […] - 2025-05-20 05:22:57
Analysts See 11% Upside For The Holdings of FTQI
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-13 08:43:46
Stifel Financial Corp Grows Stock Holdings in Guardant Health, Inc. (NASDAQ:GH)
Stifel Financial Corp lifted its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 25.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 49,927 shares of the company’s stock after purchasing an additional 10,006 shares during the period. Stifel Financial Corp’s holdings in Guardant Health were worth $1,525,000 at the end […] - 2025-05-07 05:38:58
Guardant Health, Inc. (NASDAQ:GH) Stock Holdings Raised by Hsbc Holdings PLC
Hsbc Holdings PLC lifted its stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 25.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,011 shares of the company’s stock after purchasing an additional 3,863 shares during the period. Hsbc Holdings PLC’s holdings […] - 2025-05-07 05:00:50
First Trust Advisors LP Sells 50,951 Shares of Guardant Health, Inc. (NASDAQ:GH)
First Trust Advisors LP cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 47.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,723 shares of the company’s stock after selling 50,951 shares during the quarter. First […] - 2025-05-06 05:41:07
Raymond James Financial Inc. Buys Shares of 72,364 Guardant Health, Inc. (NASDAQ:GH)
Raymond James Financial Inc. purchased a new stake in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 72,364 shares of the company’s stock, valued at approximately $2,211,000. Raymond James Financial Inc. […] - 2025-05-01 06:18:47
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Marshall Wace LLP
Marshall Wace LLP trimmed its holdings in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 99.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,085 shares of the company’s stock after selling 17,717,915 shares during the quarter. Marshall Wace LLP’s holdings in Guardant […] - 2025-05-01 05:42:53
8,118 Shares in Guardant Health, Inc. (NASDAQ:GH) Acquired by Bank of Montreal Can
Bank of Montreal Can acquired a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the 4th quarter, HoldingsChannel reports. The firm acquired 8,118 shares of the company’s stock, valued at approximately $248,000. Several other institutional investors and hedge funds have also bought and sold shares of GH. Arizona State Retirement System boosted […] - 2025-04-25 06:14:43
Rockefeller Capital Management L.P. Boosts Position in Guardant Health, Inc. (NASDAQ:GH)
Rockefeller Capital Management L.P. lifted its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 20.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,357 shares of the company’s stock after purchasing an additional 2,757 shares during the period. Rockefeller Capital Management L.P.’s holdings […] - 2025-04-24 06:00:58

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GH holdings

DateNumber of GH Shares HeldBase Market Value of GH SharesLocal Market Value of GH SharesChange in GH Shares HeldChange in GH Base ValueCurrent Price per GH Share HeldPrevious Price per GH Share Held
2025-09-26 (Friday)52,646USD 3,160,339USD 3,160,339
2025-09-25 (Thursday)52,646USD 3,168,236GH holding increased by 132141USD 3,168,2360USD 132,141 USD 60.18 USD 57.67
2025-09-24 (Wednesday)52,646USD 3,036,095USD 3,036,095
2025-09-17 (Wednesday)52,306USD 2,991,380GH holding increased by 93628USD 2,991,3800USD 93,628 USD 57.19 USD 55.4
2025-09-16 (Tuesday)52,306USD 2,897,752USD 2,897,752
2025-09-12 (Friday)51,966USD 2,852,674USD 2,852,674
2025-09-11 (Thursday)51,966GH holding increased by 680USD 2,951,409GH holding decreased by -134213USD 2,951,409680USD -134,213 USD 56.795 USD 60.165
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GH by Blackrock for IE00B3VWM098

Show aggregate share trades of GH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY680 56.795* 41.99
2025-08-21SELL-176 61.280* 41.87 Profit of 7,370 on sale
2025-07-31BUY528 40.980* 41.78
2025-06-30SELL-352 52.040* 40.93 Profit of 14,407 on sale
2025-06-25SELL-176 49.900* 40.73 Profit of 7,169 on sale
2025-06-20SELL-352 49.140* 40.55 Profit of 14,275 on sale
2025-05-30SELL-7,776 40.620* 39.66 Profit of 308,408 on sale
2025-05-23BUY202 38.000* 39.71
2025-05-19SELL-202 40.240* 39.75 Profit of 8,030 on sale
2025-05-15SELL-606 40.460* 39.74 Profit of 24,082 on sale
2025-05-12SELL-202 41.660* 39.70 Profit of 8,019 on sale
2025-05-09SELL-203 41.720* 39.68 Profit of 8,055 on sale
2025-04-30SELL-203 47.230* 39.36 Profit of 7,991 on sale
2025-04-24SELL-406 47.410* 39.00 Profit of 15,835 on sale
2025-04-17SELL-203 44.970* 38.72 Profit of 7,859 on sale
2025-04-15SELL-609 44.850* 38.58 Profit of 23,494 on sale
2025-04-14SELL-609 45.160* 38.51 Profit of 23,450 on sale
2025-04-10BUY1,980 41.140* 38.42
2025-04-09SELL-784 43.870* 38.36 Profit of 30,071 on sale
2025-04-07SELL-1,379 41.780* 38.30 Profit of 52,815 on sale
2025-04-04SELL-1,970 40.580* 38.27 Profit of 75,398 on sale
2025-03-31BUY197 42.600* 38.11
2025-03-19SELL-394 46.240* 37.30 Profit of 14,696 on sale
2025-03-14SELL-1,182 42.890* 37.05 Profit of 43,794 on sale
2025-03-13SELL-394 40.640* 37.00 Profit of 14,578 on sale
2025-03-12SELL-6,698 43.100* 36.91 Profit of 247,230 on sale
2025-03-07SELL-394 39.320* 36.80 Profit of 14,501 on sale
2025-03-06SELL-591 40.170* 36.75 Profit of 21,721 on sale
2025-03-03SELL-197 40.740* 36.52 Profit of 7,194 on sale
2025-02-28BUY17,471 42.550* 36.42
2025-02-26SELL-148 43.190* 36.21 Profit of 5,359 on sale
2025-02-25SELL-447 40.350* 36.13 Profit of 16,152 on sale
2025-02-18BUY740 48.270* 35.20
2025-02-13BUY148 46.980* 34.45
2025-02-12BUY148 45.380* 34.23
2025-02-11BUY444 43.600* 34.03
2025-02-06BUY1,332 46.090* 33.30
2025-01-27BUY148 46.980* 30.18
2024-12-30BUY740 30.540* 29.04
2024-12-06BUY592 36.870* 28.32
2024-12-05BUY148 37.110* 28.02
2024-12-04BUY740 38.110* 27.66
2024-11-29BUY740 35.610* 26.70
2024-11-27BUY592 35.100* 25.97
2024-11-26BUY148 34.370* 25.59
2024-11-21BUY740 30.980* 24.42
2024-11-20BUY444 30.680* 24.07
2024-11-18BUY1,776 28.960* 23.35
2024-11-12BUY1,184 29.730* 22.92
2024-11-08BUY740 28.610* 22.52
2024-11-07BUY2,205 28.590* 22.05
2024-11-06BUY294 25.290* 21.78
2024-10-31BUY147 21.880* 21.17
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19433,7820863,78150.2%
2025-09-18332,95475638,09052.2%
2025-09-17446,76734950,05247.0%
2025-09-16392,4440738,52353.1%
2025-09-15589,5826,8731,215,99448.5%
2025-09-12546,1481501,111,38349.1%
2025-09-11275,329798589,10846.7%
2025-09-10507,436764961,96652.7%
2025-09-09485,073477885,08154.8%
2025-09-08486,2261031,033,75347.0%
2025-09-05657,67220,3861,123,79258.5%
2025-09-04923,21768,2962,077,47344.4%
2025-09-03165,0551,304666,99924.7%
2025-09-02395,563675958,48441.3%
2025-08-29288,764501,009,21228.6%
2025-08-28216,254379525,73241.1%
2025-08-27239,916830573,57541.8%
2025-08-26225,7530475,80647.4%
2025-08-25243,9520698,40234.9%
2025-08-22329,5900782,52942.1%
2025-08-21452,603721,028,53644.0%
2025-08-20350,419291924,11537.9%
2025-08-19389,869295878,02644.4%
2025-08-18350,3206755,15846.4%
2025-08-15512,42901,189,96543.1%
2025-08-14957,0102641,683,55456.8%
2025-08-13489,3273171,398,14935.0%
2025-08-12331,838589764,51143.4%
2025-08-11347,753232844,18541.2%
2025-08-08836,7222971,838,58845.5%
2025-08-071,653,5538014,233,34139.1%
2025-08-06474,8411311,081,73743.9%
2025-08-05411,912139758,61154.3%
2025-08-04618,3971881,108,19955.8%
2025-08-01498,1004,7071,307,94838.1%
2025-07-312,347,8807,1343,644,61564.4%
2025-07-30901,860821,705,75552.9%
2025-07-29405,4201,857723,95756.0%
2025-07-28327,2642,982670,55448.8%
2025-07-25309,61817635,50748.7%
2025-07-24291,805262562,48551.9%
2025-07-23460,329590960,35847.9%
2025-07-22281,855497759,63137.1%
2025-07-21381,326599569,47067.0%
2025-07-18298,179320736,14640.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.